About ChanTest
ChanTest is a company based in Cleveland (United States) founded in 1998 was acquired by Charles River Laboratories in October 2014. ChanTest operates in a competitive market with competitors including Anabios, Metrion Biosciences, Quiver Bioscience, Antibody Analytics and Zen-Bio, among others.
- Headquarter Cleveland, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1 M (USD), Grant
Sep 17, 2012
-
Investors
Charles River Laboratories
& 2 more
-
Employee Count
Not available
-
Acquired by
Charles River Laboratories
(Oct 29, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ChanTest
Investors in ChanTest
ChanTest has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Charles River Laboratories, NIH SBIR/STTR and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked | |
|
Provider of drug discovery and preclinical development services
|
Locked | Locked | Locked |
Investor details for ChanTest
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ChanTest
Investment portfolio details for ChanTest
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ChanTest
Detailed financials for ChanTest
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chantest Comparisons
Peer comparison for ChanTest
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ChanTest
ChanTest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Metrion Biosciences, Quiver Bioscience, Antibody Analytics and Zen-Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ex-vivo human tissue studies are performed for preclinical drug discovery.
|
|
| Locked | Locked | Locked |
Ion channel screening and cardiac safety profiling services are provided.
|
|
| Locked | Locked | Locked |
Developer of transformational medicines for neurological disorders
|
|
| Locked | Locked | Locked |
Antibody analytics and characterization services are provided.
|
|
| Locked | Locked | Locked |
Cell-based solutions are provided to accelerate therapy discovery and development.
|
|
| Locked | Locked | Locked |
Drug-target interactions are quantified via specialized assay services.
|
Detailed competitors of ChanTest
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chantest
Complete news archive for ChanTest
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ChanTest
ChanTest was founded in 1998 and raised its 1st funding round 9 years after it was founded.
ChanTest is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.
ChanTest was established in 1998 in Cleveland, United States, as a contract research organization specializing in ion channel and GPCR assays. GLP and non-GLP services, including reagents, validated cell lines, and pre-clinical cardiac risk assessments, were offered to pharmaceutical and biotech firms. Compounds for over 300 companies were tested. Applied Cell Sciences was acquired in 2009, and the company was purchased by Charles River in 2014 for 54 million.
ChanTest's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.
ChanTest has 3 investors. Key investors include Charles River Laboratories, NIH SBIR/STTR, and Ampersand Capital Partners.